Report Detail
Global Biosimilars Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
- RnM3449020 |
- 10 March, 2020 |
- Global |
- 104 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Market Overview
The global Biosimilars market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 17.2% in the forecast period of 2020 to 2025 and will expected to reach USD 9643.4 million by 2025, from USD 5111 million in 2019.
The Biosimilars market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Biosimilars market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Biosimilars market has been segmented into
Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
Peptides (Glucagon, Calcitonin)
By Application, Biosimilars has been segmented into:
Oncology
Blood Disorders
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biosimilars market presented in the report. This section sheds light on the sales growth of different regional and country-level Biosimilars markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biosimilars market.
The report offers in-depth assessment of the growth and other aspects of the Biosimilars market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Biosimilars Market Share Analysis
Biosimilars competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biosimilars sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biosimilars sales, revenue and market share for each player covered in this report.
The major players covered in Biosimilars are:
Pfizer
Celltrion
Amgen Inc
Sandoz International GmbH
F. Hoffmann-La Roche
Teva Pharmaceuticals Industries
Dr. Reddy’s Laboratories
Biocon
Samsung Bioepis
Among other players domestic and global, Biosimilars market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biosimilars product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biosimilars, with price, sales, revenue and global market share of Biosimilars in 2018 and 2019.
Chapter 3, the Biosimilars competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biosimilars breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Biosimilars market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Biosimilars sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
- 1.1 Biosimilars Introduction
- 1.2 Market Analysis by Type
- 1.2.1 Overview: Global Biosimilars Revenue by Type: 2015 VS 2019 VS 2025
- 1.2.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
- 1.2.3 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
- 1.2.4 Peptides (Glucagon, Calcitonin)
- 1.3 Market Analysis by Application
- 1.3.1 Overview: Global Biosimilars Revenue by Application: 2015 VS 2019 VS 2025
- 1.3.2 Oncology
- 1.3.3 Blood Disorders
- 1.4 Overview of Global Biosimilars Market
- 1.4.1 Global Biosimilars Market Status and Outlook (2015-2025)
- 1.4.2 North America (United States, Canada and Mexico)
- 1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
- 1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- 1.4.5 South America, Middle East & Africa
- 1.5 Market Dynamics
- 1.5.1 Market Opportunities
- 1.5.2 Market Risk
- 1.5.3 Market Driving Force
2 Manufacturers Profiles
- 2.1 Pfizer
- 2.1.1 Pfizer Details
- 2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
- 2.1.3 Pfizer SWOT Analysis
- 2.1.4 Pfizer Product and Services
- 2.1.5 Pfizer Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
- 2.2 Celltrion
- 2.2.1 Celltrion Details
- 2.2.2 Celltrion Major Business and Total Revenue (Financial Highlights) Analysis
- 2.2.3 Celltrion SWOT Analysis
- 2.2.4 Celltrion Product and Services
- 2.2.5 Celltrion Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
- 2.3 Amgen Inc
- 2.3.1 Amgen Inc Details
- 2.3.2 Amgen Inc Major Business and Total Revenue (Financial Highlights) Analysis
- 2.3.3 Amgen Inc SWOT Analysis
- 2.3.4 Amgen Inc Product and Services
- 2.3.5 Amgen Inc Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
- 2.4 Sandoz International GmbH
- 2.4.1 Sandoz International GmbH Details
- 2.4.2 Sandoz International GmbH Major Business and Total Revenue (Financial Highlights) Analysis
- 2.4.3 Sandoz International GmbH SWOT Analysis
- 2.4.4 Sandoz International GmbH Product and Services
- 2.4.5 Sandoz International GmbH Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
- 2.5 F. Hoffmann-La Roche
- 2.5.1 F. Hoffmann-La Roche Details
- 2.5.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
- 2.5.3 F. Hoffmann-La Roche SWOT Analysis
- 2.5.4 F. Hoffmann-La Roche Product and Services
- 2.5.5 F. Hoffmann-La Roche Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
- 2.6 Teva Pharmaceuticals Industries
- 2.6.1 Teva Pharmaceuticals Industries Details
- 2.6.2 Teva Pharmaceuticals Industries Major Business and Total Revenue (Financial Highlights) Analysis
- 2.6.3 Teva Pharmaceuticals Industries SWOT Analysis
- 2.6.4 Teva Pharmaceuticals Industries Product and Services
- 2.6.5 Teva Pharmaceuticals Industries Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
- 2.7 Dr. Reddy’s Laboratories
- 2.7.1 Dr. Reddy’s Laboratories Details
- 2.7.2 Dr. Reddy’s Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
- 2.7.3 Dr. Reddy’s Laboratories SWOT Analysis
- 2.7.4 Dr. Reddy’s Laboratories Product and Services
- 2.7.5 Dr. Reddy’s Laboratories Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
- 2.8 Biocon
- 2.8.1 Biocon Details
- 2.8.2 Biocon Major Business and Total Revenue (Financial Highlights) Analysis
- 2.8.3 Biocon SWOT Analysis
- 2.8.4 Biocon Product and Services
- 2.8.5 Biocon Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
- 2.9 Samsung Bioepis
- 2.9.1 Samsung Bioepis Details
- 2.9.2 Samsung Bioepis Major Business and Total Revenue (Financial Highlights) Analysis
- 2.9.3 Samsung Bioepis SWOT Analysis
- 2.9.4 Samsung Bioepis Product and Services
- 2.9.5 Samsung Bioepis Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
- 3.1 Global Biosimilars Sales and Market Share by Manufacturer (2018-2019)
- 3.2 Global Biosimilars Revenue and Market Share by Manufacturer (2018-2019)
- 3.3 Market Concentration Rate
- 3.3.1 Top 3 Biosimilars Manufacturer Market Share in 2019
- 3.3.2 Top 6 Biosimilars Manufacturer Market Share in 2019
- 3.4 Market Competition Trend
4 Global Market Analysis by Regions
- 4.1 Global Biosimilars Sales, Revenue and Market Share by Regions
- 4.1.1 Global Biosimilars Sales and Market Share by Regions (2015-2020)
- 4.1.2 Global Biosimilars Revenue and Market Share by Regions (2015-2020)
- 4.2 North America Biosimilars Sales and Growth Rate (2015-2020)
- 4.3 Europe Biosimilars Sales and Growth Rate (2015-2020)
- 4.4 Asia-Pacific Biosimilars Sales and Growth Rate (2015-2020)
- 4.5 South America Biosimilars Sales and Growth Rate (2015-2020)
- 4.6 Middle East and Africa Biosimilars Sales and Growth Rate (2015-2020)
5 North America by Country
- 5.1 North America Biosimilars Sales, Revenue and Market Share by Country
- 5.1.1 North America Biosimilars Sales and Market Share by Country (2015-2020)
- 5.1.2 North America Biosimilars Revenue and Market Share by Country (2015-2020)
- 5.2 United States Biosimilars Sales and Growth Rate (2015-2020)
- 5.3 Canada Biosimilars Sales and Growth Rate (2015-2020)
- 5.4 Mexico Biosimilars Sales and Growth Rate (2015-2020)
6 Europe by Country
- 6.1 Europe Biosimilars Sales, Revenue and Market Share by Country
- 6.1.1 Europe Biosimilars Sales and Market Share by Country (2015-2020)
- 6.1.2 Europe Biosimilars Revenue and Market Share by Country (2015-2020)
- 6.2 Germany Biosimilars Sales and Growth Rate (2015-2020)
- 6.3 UK Biosimilars Sales and Growth Rate (2015-2020)
- 6.4 France Biosimilars Sales and Growth Rate (2015-2020)
- 6.5 Russia Biosimilars Sales and Growth Rate (2015-2020)
- 6.6 Italy Biosimilars Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
- 7.1 Asia-Pacific Biosimilars Sales, Revenue and Market Share by Regions
- 7.1.1 Asia-Pacific Biosimilars Sales and Market Share by Regions (2015-2020)
- 7.1.2 Asia-Pacific Biosimilars Revenue and Market Share by Regions (2015-2020)
- 7.2 China Biosimilars Sales and Growth Rate (2015-2020)
- 7.3 Japan Biosimilars Sales and Growth Rate (2015-2020)
- 7.4 Korea Biosimilars Sales and Growth Rate (2015-2020)
- 7.5 India Biosimilars Sales and Growth Rate (2015-2020)
- 7.6 Southeast Asia Biosimilars Sales and Growth Rate (2015-2020)
- 7.7 Australia Biosimilars Sales and Growth Rate (2015-2020)
8 South America by Country
- 8.1 South America Biosimilars Sales, Revenue and Market Share by Country
- 8.1.1 South America Biosimilars Sales and Market Share by Country (2015-2020)
- 8.1.2 South America Biosimilars Revenue and Market Share by Country (2015-2020)
- 8.2 Brazil Biosimilars Sales and Growth Rate (2015-2020)
- 8.3 Argentina Biosimilars Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
- 9.1 Middle East & Africa Biosimilars Sales, Revenue and Market Share by Country
- 9.1.1 Middle East & Africa Biosimilars Sales and Market Share by Country (2015-2020)
- 9.1.2 Middle East & Africa Biosimilars Revenue and Market Share by Country (2015-2020)
- 9.2 Saudi Arabia Biosimilars Sales and Growth Rate (2015-2020)
- 9.3 Turkey Biosimilars Sales and Growth Rate (2015-2020)
- 9.4 Egypt Biosimilars Sales and Growth Rate (2015-2020)
- 9.5 South Africa Biosimilars Sales and Growth Rate (2015-2020)
10 Market Segment by Type
- 10.1 Global Biosimilars Sales and Market Share by Type (2015-2020)
- 10.2 Global Biosimilars Revenue and Market Share by Type (2015-2020)
- 10.3 Global Biosimilars Price by Type (2015-2020)
11 Global Biosimilars Market Segment by Application
- 11.1 Global Biosimilars Sales Market Share by Application (2015-2020)
- 11.2 Global Biosimilars Revenue Market Share by Application (2015-2020)
- 11.3 Global Biosimilars Price by Application (2015-2020)
12 Market Forecast
- 12.1 Global Biosimilars Sales, Revenue and Growth Rate (2021-2025)
- 12.2 Biosimilars Market Forecast by Regions (2021-2025)
- 12.2.1 North America Biosimilars Market Forecast (2021-2025)
- 12.2.2 Europe Biosimilars Market Forecast (2021-2025)
- 12.2.3 Asia-Pacific Biosimilars Market Forecast (2021-2025)
- 12.2.4 South America Biosimilars Market Forecast (2021-2025)
- 12.2.5 Middle East & Africa Biosimilars Market Forecast (2021-2025)
- 12.3 Biosimilars Market Forecast by Type (2021-2025)
- 12.3.1 Global Biosimilars Sales Forecast by Type (2021-2025)
- 12.3.2 Global Biosimilars Market Share Forecast by Type (2021-2025)
- 12.4 Biosimilars Market Forecast by Application (2021-2025)
- 12.4.1 Global Biosimilars Sales Forecast by Application (2021-2025)
- 12.4.2 Global Biosimilars Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
- 13.1 Sales Channel
- 13.1.1 Direct Marketing
- 13.1.2 Indirect Marketing
- 13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
- 15.1 Methodology
- 15.2 Data Source
- 15.3 Disclaimer
Summary:
Get latest Market Research Reports on Biosimilars . Industry analysis & Market Report on Biosimilars is a syndicated market report, published as Global Biosimilars Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Biosimilars market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
